# Playtika Holding Corp.: financial statements, quarterly

PLTK · Nasdaq · CIK 1828016 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pltk.md) · [Financials](/companies/pltk/financials.md) · [Filings](/companies/pltk/filings.md) · [Insiders](/companies/pltk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pltk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [630](/filings/0001828016-24-000035.md) | [638 d](/filings/0001828016-26-000010.md) | [651](/filings/0001828016-25-000026.md) | [627](/filings/0001828016-25-000038.md) | [621](/filings/0001828016-25-000048.md) | [650 d](/filings/0001828016-26-000010.md) | [706](/filings/0001828016-26-000034.md) | [696](/filings/0001828016-26-000047.md) | [675](/filings/0001828016-25-000048.md) | [679 d](/filings/0001828016-26-000010.md) | [745](/filings/0001828016-26-000034.md) | [731](/filings/0001828016-26-000047.md) |
| Cost of revenue | $m | [174](/filings/0001828016-24-000035.md) | [181 d](/filings/0001828016-26-000010.md) | [177](/filings/0001828016-25-000026.md) | [168](/filings/0001828016-25-000038.md) | [168](/filings/0001828016-25-000048.md) | [179 d](/filings/0001828016-26-000010.md) | [197](/filings/0001828016-26-000034.md) | [196](/filings/0001828016-26-000047.md) | [178](/filings/0001828016-25-000048.md) | [187 d](/filings/0001828016-26-000010.md) | [192](/filings/0001828016-26-000034.md) | [193](/filings/0001828016-26-000047.md) |
| Research and development | $m | [102](/filings/0001828016-24-000035.md) | [102 d](/filings/0001828016-26-000010.md) | [107](/filings/0001828016-25-000026.md) | [101](/filings/0001828016-25-000038.md) | [99.2](/filings/0001828016-25-000048.md) | [96.3 d](/filings/0001828016-26-000010.md) | [104](/filings/0001828016-26-000034.md) | [115](/filings/0001828016-26-000047.md) | [98.8](/filings/0001828016-25-000048.md) | [110 d](/filings/0001828016-26-000010.md) | [98.0](/filings/0001828016-26-000034.md) | [96.4](/filings/0001828016-26-000047.md) |
| Operating income | $m | [90.0](/filings/0001828016-24-000035.md) | [120 d](/filings/0001828016-26-000010.md) | [98.1](/filings/0001828016-25-000026.md) | [141](/filings/0001828016-25-000038.md) | [97.5](/filings/0001828016-25-000048.md) | [55.3 d](/filings/0001828016-26-000010.md) | [67.8](/filings/0001828016-26-000034.md) | [110](/filings/0001828016-26-000047.md) | [98.4](/filings/0001828016-25-000048.md) | [(281) d](/filings/0001828016-26-000010.md) | [(49.6)](/filings/0001828016-26-000034.md) | [135](/filings/0001828016-26-000047.md) |
| Interest expense | $m | [39.5](/filings/0001828016-23-000042.md) | [40.9 d](/filings/0001828016-26-000010.md) | [39.0](/filings/0001828016-24-000019.md) | [38.9](/filings/0001828016-25-000038.md) | [38.7](/filings/0001828016-25-000048.md) | [38.6 d](/filings/0001828016-26-000010.md) | [36.1](/filings/0001828016-26-000034.md) | [36.5](/filings/0001828016-26-000047.md) | [36.6](/filings/0001828016-25-000048.md) | [34.1 d](/filings/0001828016-26-000010.md) | [34.7](/filings/0001828016-26-000034.md) | [37.8](/filings/0001828016-26-000047.md) |
| Income tax | $m | [26.9](/filings/0001828016-24-000035.md) | [50.1 d](/filings/0001828016-26-000010.md) | [21.9](/filings/0001828016-25-000026.md) | [33.7](/filings/0001828016-25-000038.md) | [24.4](/filings/0001828016-25-000048.md) | [38.3 d](/filings/0001828016-26-000010.md) | [10.5](/filings/0001828016-26-000034.md) | [11.9](/filings/0001828016-26-000047.md) | [19.0](/filings/0001828016-25-000048.md) | [(7.9) d](/filings/0001828016-26-000010.md) | [(16.3)](/filings/0001828016-26-000034.md) | [20.5](/filings/0001828016-26-000047.md) |
| Net income | $m | [37.9](/filings/0001828016-24-000035.md) | [37.3 d](/filings/0001828016-26-000010.md) | [53.0](/filings/0001828016-25-000048.md) | [86.6](/filings/0001828016-25-000048.md) | [39.3](/filings/0001828016-25-000048.md) | [(16.7) d](/filings/0001828016-26-000010.md) | [30.6](/filings/0001828016-26-000047.md) | [33.2](/filings/0001828016-26-000047.md) | [39.1](/filings/0001828016-25-000048.md) | [(309) d](/filings/0001828016-26-000010.md) | [(57.5)](/filings/0001828016-26-000047.md) | [48.0](/filings/0001828016-26-000047.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001828016-24-000035.md) | not reported | [0.14](/filings/0001828016-25-000026.md) | [0.23](/filings/0001828016-25-000038.md) | [0.11](/filings/0001828016-25-000048.md) | not reported | [0.08](/filings/0001828016-26-000034.md) | [0.09](/filings/0001828016-26-000047.md) | [0.11](/filings/0001828016-25-000048.md) | not reported | [(0.15)](/filings/0001828016-26-000034.md) | [0.13](/filings/0001828016-26-000047.md) |
| Basic EPS | $ per share | [0.10](/filings/0001828016-24-000035.md) | not reported | [0.14](/filings/0001828016-25-000026.md) | [0.23](/filings/0001828016-25-000038.md) | [0.11](/filings/0001828016-25-000048.md) | not reported | [0.08](/filings/0001828016-26-000034.md) | [0.09](/filings/0001828016-26-000047.md) | [0.11](/filings/0001828016-25-000048.md) | not reported | [(0.15)](/filings/0001828016-26-000034.md) | [0.13](/filings/0001828016-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [878](/filings/0001828016-23-000042.md) | [1,030](/filings/0001828016-25-000011.md) | [1,016](/filings/0001828016-24-000019.md) | [710](/filings/0001828016-24-000029.md) | [1,146](/filings/0001828016-24-000035.md) | [566](/filings/0001828016-26-000010.md) | [435](/filings/0001828016-25-000026.md) | [501](/filings/0001828016-25-000038.md) | [588](/filings/0001828016-25-000048.md) | [684](/filings/0001828016-26-000047.md) | [779](/filings/0001828016-26-000034.md) | [439](/filings/0001828016-26-000047.md) |
| Current assets | $m | [1,168](/filings/0001828016-23-000042.md) | [1,351](/filings/0001828016-25-000011.md) | [1,343](/filings/0001828016-24-000019.md) | [1,399](/filings/0001828016-24-000029.md) | [1,470](/filings/0001828016-24-000035.md) | [873](/filings/0001828016-26-000010.md) | [828](/filings/0001828016-25-000026.md) | [917](/filings/0001828016-25-000038.md) | [993](/filings/0001828016-25-000048.md) | [1,064](/filings/0001828016-26-000047.md) | [1,069](/filings/0001828016-26-000034.md) | [711](/filings/0001828016-26-000047.md) |
| Total assets | $m | [2,978](/filings/0001828016-23-000042.md) | [3,175](/filings/0001828016-25-000011.md) | [3,145](/filings/0001828016-24-000019.md) | [3,175](/filings/0001828016-24-000029.md) | [3,189](/filings/0001828016-24-000035.md) | [3,639](/filings/0001828016-26-000010.md) | [3,577](/filings/0001828016-25-000026.md) | [3,637](/filings/0001828016-25-000038.md) | [3,688](/filings/0001828016-25-000048.md) | [3,719](/filings/0001828016-26-000047.md) | [3,687](/filings/0001828016-26-000034.md) | [3,293](/filings/0001828016-26-000047.md) |
| Current liabilities | $m | [401](/filings/0001828016-23-000042.md) | [540](/filings/0001828016-25-000011.md) | [492](/filings/0001828016-24-000019.md) | [462](/filings/0001828016-24-000029.md) | [452](/filings/0001828016-24-000035.md) | [559](/filings/0001828016-26-000010.md) | [458](/filings/0001828016-25-000026.md) | [665](/filings/0001828016-25-000038.md) | [703](/filings/0001828016-25-000048.md) | [968](/filings/0001828016-26-000047.md) | [904](/filings/0001828016-26-000034.md) | [625](/filings/0001828016-26-000047.md) |
| Total liabilities | $m | [3,260](/filings/0001828016-23-000042.md) | [3,397](/filings/0001828016-25-000011.md) | [3,325](/filings/0001828016-24-000019.md) | [3,288](/filings/0001828016-24-000029.md) | [3,287](/filings/0001828016-24-000035.md) | [3,770](/filings/0001828016-26-000010.md) | [3,694](/filings/0001828016-25-000026.md) | [3,725](/filings/0001828016-25-000038.md) | [3,763](/filings/0001828016-25-000048.md) | [4,130](/filings/0001828016-26-000047.md) | [4,150](/filings/0001828016-26-000034.md) | [3,693](/filings/0001828016-26-000047.md) |
| Long-term debt | $m | [2,402](/filings/0001828016-23-000042.md) | [2,400](/filings/0001828016-25-000011.md) | [2,397](/filings/0001828016-24-000019.md) | [2,394](/filings/0001828016-24-000029.md) | [2,391](/filings/0001828016-24-000035.md) | [2,389](/filings/0001828016-26-000010.md) | [2,386](/filings/0001828016-25-000026.md) | [2,383](/filings/0001828016-25-000038.md) | [2,381](/filings/0001828016-25-000048.md) | [2,378](/filings/0001828016-26-000047.md) | [2,375](/filings/0001828016-26-000034.md) | [2,373](/filings/0001828016-26-000047.md) |
| Current portion of debt | $m | [16.9](/filings/0001828016-23-000042.md) | [16.8](/filings/0001828016-25-000011.md) | [16.2](/filings/0001828016-24-000019.md) | [16.5](/filings/0001828016-24-000029.md) | [11.7](/filings/0001828016-24-000035.md) | [11.6](/filings/0001828016-26-000010.md) | [11.4](/filings/0001828016-25-000026.md) | [11.1](/filings/0001828016-25-000038.md) | [10.8](/filings/0001828016-25-000048.md) | [11.1](/filings/0001828016-26-000047.md) | [11.1](/filings/0001828016-26-000034.md) | [11.0](/filings/0001828016-26-000047.md) |
| Shareholders' equity | $m | [(282)](/filings/0001828016-24-000035.md) | [(222)](/filings/0001828016-26-000010.md) | [(180)](/filings/0001828016-25-000048.md) | [(113)](/filings/0001828016-25-000048.md) | [(98.0)](/filings/0001828016-25-000048.md) | [(131)](/filings/0001828016-26-000047.md) | [(117)](/filings/0001828016-26-000047.md) | [(87.8)](/filings/0001828016-26-000047.md) | [(74.8)](/filings/0001828016-25-000048.md) | [(411)](/filings/0001828016-26-000047.md) | [(463)](/filings/0001828016-26-000047.md) | [(400)](/filings/0001828016-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [109 d](/filings/0001828016-24-000035.md) | [179 d](/filings/0001828016-26-000010.md) | [29.6](/filings/0001828016-25-000026.md) | [151 d](/filings/0001828016-25-000038.md) | [157 d](/filings/0001828016-25-000048.md) | [153 d](/filings/0001828016-26-000010.md) | [18.8](/filings/0001828016-26-000034.md) | [146 d](/filings/0001828016-26-000047.md) | [117 d](/filings/0001828016-25-000048.md) | [286 d](/filings/0001828016-26-000010.md) | [22.8](/filings/0001828016-26-000034.md) | [28.7 d](/filings/0001828016-26-000047.md) |
| Capital expenditure | $m | [7.6 d](/filings/0001828016-24-000035.md) | [15.8 d](/filings/0001828016-26-000010.md) | [14.0](/filings/0001828016-25-000026.md) | [9.3 d](/filings/0001828016-25-000038.md) | [4.8 d](/filings/0001828016-25-000048.md) | [12.8 d](/filings/0001828016-26-000010.md) | [10.4](/filings/0001828016-26-000034.md) | [4.8 d](/filings/0001828016-26-000047.md) | [10.4 d](/filings/0001828016-25-000048.md) | [10.7 d](/filings/0001828016-26-000010.md) | [5.7](/filings/0001828016-26-000034.md) | [8.4 d](/filings/0001828016-26-000047.md) |
| Dividends paid | $m | [0.0 d](/filings/0001828016-24-000035.md) | [0.0 d](/filings/0001828016-26-000010.md) | [0.0](/filings/0001828016-25-000026.md) | [37.1 d](/filings/0001828016-25-000038.md) | [37.2 d](/filings/0001828016-25-000048.md) | [37.2 d](/filings/0001828016-26-000010.md) | [37.3](/filings/0001828016-26-000034.md) | [37.6 d](/filings/0001828016-26-000047.md) | [37.6 d](/filings/0001828016-25-000048.md) | [37.7 d](/filings/0001828016-26-000010.md) | [37.7](/filings/0001828016-26-000034.md) | [0.0 d](/filings/0001828016-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [413](/filings/0001828016-23-000042.md) | [365](/filings/0001828016-24-000019.md) | [366](/filings/0001828016-24-000029.md) | [368](/filings/0001828016-24-000035.md) | [371](/filings/0001828016-25-000026.md) | [372](/filings/0001828016-25-000038.md) | [373](/filings/0001828016-25-000048.md) | [376](/filings/0001828016-26-000034.md) | [376](/filings/0001828016-26-000047.md) | [368](/filings/0001828016-25-000048.md) | [378](/filings/0001828016-26-000034.md) | [382](/filings/0001828016-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 381,418,186 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001828016-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.